MacroGenics Total Assets from 2010 to 2025
| MGNX Stock | USD 1.40 0.03 2.19% |
Total Assets | First Reported 2011-12-31 | Previous Quarter 245.4 M | Current Value 270.8 M | Quarterly Volatility 96.8 M |
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.6 M, Interest Expense of 1.2 M or Selling General Administrative of 39.9 M, as well as many indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.0 or PTB Ratio of 1.84. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
MacroGenics | Total Assets | Build AI portfolio with MacroGenics Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MacroGenics Stock Analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.